 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | IMeBio |
| Street 1: | 11 rue Réné Camphin |
| Street 2: | |
| City: | Fontaine |
| Province: | |
| Post Code: | 38600 |
| Country: | France |
| Phone: | 0480048420 |
| Organization Email: | contact@imebio.com |
| Web Site: | http://www.imebio.com/ |
| Other Online Presence: | www.linkedin.com/company/imebio |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 51126687600057 |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | None |
| Organization Description: | |
| At IMeBIO, we design, manufacture, and market mobile BSL2 and BSL3 biological containment labs for organizations involved in the study of pathogens, whether to fight bioterrorism, pandemics, or other public health risks. One of our company's key investors is Institut Mérieux, a French industrial biology company committed to fighting infectious diseases and cancers around the world. More than 20 laboratories have been built and installed on the European, African, Asian and American continents and have been operating continuously for more than eight years. Among them, there are 7 laboratories built for tuberculosis control research.Our laboratories are, above all, designed to enable the medical and scientific sector to fight against dangerous infections. We are aware of the need to deploy robust and reliable units quickly. This is why we want to collaborate with you in the fight against tuberculosis. |
|
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Delivery of health services and care Research and Development |
Other Organization Information | |
| Total number of staff in your organization: | 11 - 25 |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Internet search |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | No |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| IMeBio was built to meet the need for mobile and modular units in developing countries. Beyond that we have a company that exists since 2006 that builds permanent laboratories in France. Therefore, the preparation of containers and the installation of specific equipment are ensured by a diligent team with a deep knowledge of laboratories and clean rooms. We work with health organizations such as Biomerieux, Institut Pasteur, UNOPS, etc. We are official UNOPS supplier for BSL2 and BSL3 mobile laboratories for 5 years. |
|
Geographical Reach | |
| Which country is your headquarters located in: | France |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Democratic Republic of Timor-Leste Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Indonesia Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Mongolia Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Republic of Moldova Republic of Montenegro Republic of Serbia Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan Suriname Sweden Switzerland Syrian Arab Republic Tajikistan Thailand The Former Yugoslav Rep of Macedonia Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Yemen Zambia Zimbabwe |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB-HIV: In 2018 at Laos we built a laboratory for TB-HIV diagnosis for the Fondation Mérieux. Laboratory Strengthening: The design of our modules is based on the strictest international regulations as well as French and European labor law. Our modules protect the operator and samples through restricted access, door locking, airlocks, air filtration and pressure cascades. Different levels of badges can be set up to enhance security. New Diagnostics: In 2017 at Mali we built a mobile laboratory for TB diagnosis for the Fondation Mérieux. In 2019 at Nepal we built a mobile laboratory for TB diagnosis for the IDA. In 2019 at Malawi we built a mobile laboratory for TB diagnosis for the IDA. In 2019 at Nepal we built a mobile laboratory for TB diagnosis for the IDA. In 2020 at Burkina Faso we built a mobile laboratory for TB diagnosis for UNOPS. In 2020 at Senegal we built a mobile laboratory for TB diagnosis for the Health Ministere of Senegal. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | October 28, 2020 |
| Last updated: | October 28, 2020 |